Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 102 results for "Myeloproliferative Neoplasms (MPN)".

Thumbnail for RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

MPN - 120

RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

Naseema Gangat

Poster Presenter: Naseema Gangat

Thumbnail for Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets =50Χ109/L at Initiation (TRIPAC)

MPN - 1200

Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets =50Χ109/L at Initiation (TRIPAC)

Faizan Sattar

Poster Presenter: Faizan Sattar

Previous 1 2 3 4 5 6 7...12 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

MPN - 1206

Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

Mark Benton

Poster Presenter: Mark Benton

Thumbnail for Arterial and Venous Thrombosis in Myeloproliferative Neoplasm Hospitalizations: Distinct Associations With Mortality and Resource Utilization

MPN - 1235

Arterial and Venous Thrombosis in Myeloproliferative Neoplasm Hospitalizations: Distinct Associations With Mortality and Resource Utilization

Priyanka Nagdev

Poster Presenter: Priyanka Nagdev

Thumbnail for Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis

MPN - 1268

Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

Thumbnail for KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

MPN - 1280

KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

Dongni Yi

Poster Presenter: Dongni Yi

Thumbnail for Direct Oral Anticoagulants Versus Warfarin in Philadelphia-Negative Myeloproliferative Neoplasms With Atrial Fibrillation: A Propensity-Matched Retrospective Cohort Study

MPN - 1283

Direct Oral Anticoagulants Versus Warfarin in Philadelphia-Negative Myeloproliferative Neoplasms With Atrial Fibrillation: A Propensity-Matched Retrospective Cohort Study

Anmol Kumar

Poster Presenter: Anmol Kumar

Thumbnail for Efficacy and Safety of Ropeginterferon in Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis

MPN - 129

Efficacy and Safety of Ropeginterferon in Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis

Mahmood Aldapt

Poster Presenter: Mahmood Aldapt

Thumbnail for Real-World Experience With Ropeginterferon Alfa-2b in Polycythemia Vera and Essential Thrombocythemia: Practice Patterns, Tolerability, and Hematologic Response at a Single Academic Center

MPN - 1319

Real-World Experience With Ropeginterferon Alfa-2b in Polycythemia Vera and Essential Thrombocythemia: Practice Patterns, Tolerability, and Hematologic Response at a Single Academic Center

Katherine Feder

Poster Presenter: Katherine Feder

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors